A STABILITY-INDICATING HPLC METHOD FOR THE DETERMINATION OF POTENTIAL IMPURITIES IN A NEW FIXED DOSE COMBINATION OF DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS USED IN THE FIRST LINE TREATMENT OF HIV-1 INFECTION. Int. Res. J. Pharm. 2018;9(5):90-99. Accessed November 2, 2026. https://irjponline.org/index.php/irjp/article/view/1071